Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis

References

• The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008;89:505–22
   PubMed Web of Science ®Google Scholar
• Meirow D, Laufer N, Schenker JG. Ovulation induction in polycystic ovary syndrome: a review of conservative and new treatment modalities. Eur J Obstet Gynecol Reprod Biol 1993;50:123–31
   PubMed Web of Science ®Google Scholar
• Legro RS, Brzysli RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 2014;371:119–29
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25
   Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7
   PubMed Web of Science ®Google Scholar
• Misso ML, Wong JLA, Teede HJ, et al. Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Hum Reprod Update 2012;18:301–12
   PubMed Web of Science ®Google Scholar
• Franks S, Adams J, Mason H, Polson D. Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynecol 1985;12:605–32
   Google Scholar
• Kurabayashi T, Suzuli M, Fujita K, et al. Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2006;126:201–5
   PubMed Web of Science ®Google Scholar
• He D, Jiang F. Meta-analysis of letrozole versus clomiphene citrate in polycystic ovary syndrome. Reprod Biomed Online 2011;23:91–6
   PubMed Web of Science ®Google Scholar
• Casper RF, Mitwally MF. A historical perspective of aromatase inhibitors for ovulation induction. Fertil Steril 2012;98:1352–5
   PubMed Web of Science ®Google Scholar
• Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001;75:305–9
   PubMed Web of Science ®Google Scholar
• Pavone ME, Bulun SE. Clinical review: the use of aromatase inhibitors for ovulation induction and superovulation. J Clin Endocrinol Metab 2013;98:1838–44
   PubMed Web of Science ®Google Scholar
• Requena A, Herrero J, Landeras J, et al. Reproductive Endocrinology Interest Group of Spanish Society of Fertility. Use of letrozole in assisted reproduction: a systematic review and meta-analysis. Hum Reprod Update 2008;14:571–82
   PubMed Web of Science ®Google Scholar
• Pritts E. Letrozole for ovulation induction and controlled ovarian hyperstimulation. Curr Opin Obstet Gyn 2010;22:289–94
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:332–9
   Web of Science ®Google Scholar
• Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. London: The Cochrane Collaboration; 2011
   Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altmann DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557–60
   PubMed Web of Science ®Google Scholar
• Begum MR, Ferdous J, Begum A, Quadir E. Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertil Steril 2009;92:853–7
   PubMed Web of Science ®Google Scholar
• Zeinalzadeh M, Basirat Z, Esmailpour M. Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. J Reprod Med 2010;55:36–40
   PubMed Web of Science ®Google Scholar
• Kar S. Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. J Hum Reprod Sci 2012;5:262–5
   PubMedGoogle Scholar
• Bayar U, Kiran S, Coskun A, Gezer S. Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertil Steril 2006;5:1447–51
   Web of Science ®Google Scholar
• Dehbashi S, Kazerooni T, Robati M, et al. Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iran J Med Sci 2009;1:19–26
   Google Scholar
• Ray PB, Ray A, Chakraborti PS. Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Arch Gynecol Obstet 2012;285:873–7
   PubMed Web of Science ®Google Scholar
• Roy KK, Baruah J, Singla S, et al. A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. J Hum Reprod Sci 2012;5:20–5
   PubMedGoogle Scholar
• Atay V, Cam C, Muhcu M, et al. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J Int Med Res 2006;1:73–6
   Google Scholar
• Badawy A, Aal IA, Abulatta M, Caballero AE. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertil Steril 2009;3:849–52
   Web of Science ®Google Scholar
• Franik S, Kremer JA, Nelen WL, Farquhar C. Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev 2014;2:CD010287
   PubMed Web of Science ®Google Scholar
• Young SL, Opsahl MS, Fritz MA. Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women. Fertil Steril 1999;71:639–44
   PubMed Web of Science ®Google Scholar
• Franasiak JM, Holoch KJ, Yuan L, et al. Prospective assessment of midsecretory endometrial leukemia inhibitor factor expression versus ανβ3 testing in women with unexplained infertility. Fertil Steril 2014;101:1724–31
   PubMed Web of Science ®Google Scholar
• Miller PB, Parnell BA, Bushnell G, et al. Endometrial receptivity defects during IVF cycles with and without letrozole. Hum Reprod 2012;27:881–8
   PubMed Web of Science ®Google Scholar
• Wallace KL, Johnson V, Sopelak V, Hines R. Clomiphene citrate versus letrozole: molecular analysis of the endometrium in women with polycystic ovary syndrome. Fertile Steril 2011;96:1051–6
   PubMed Web of Science ®Google Scholar
• Biljan M, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril 2005;84: O–231, Abstract 1033
   Google Scholar
• Tiboni GM. Aromatase inhibitors and teratogenesis. Fertil Steril 2004;81:1158
   PubMed Web of Science ®Google Scholar
• Tulandi T, Martin J, Al-Fadhii R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 2006;85:1761–5
   PubMed Web of Science ®Google Scholar
• Casper RF, Mitwally MF. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. Clin Obstet Gynecol 2011;54:685–95
   PubMed Web of Science ®Google Scholar
• Sharma S, Ghosh S, Singh S, et al. Congenital malformations among babies born following letrozole or clomiphene for infertility treatment. PLoS One 2014;9:e108219
   Google Scholar
• Reefhuis J, Honein MA, Schieve LA, Rasmussen SA, National Birth Defects Prevention Study. Use of clomiphene citrate and birth defects, National birth defects prevention study, 1997-2005. Hum Reprod 2011;26:451–7
   PubMed Web of Science ®Google Scholar
• Davies MJ, Moore VM, Willson KL, et al. Reproductive technologies and the risk of birth defects. N Engl J Med 2012;366:1803–13
   PubMed Web of Science ®Google Scholar
• Palomba S. Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab 2015;100:1742–7
   PubMed Web of Science ®Google Scholar